PetMed Express Appoints Matt Hulett, Former Rosetta Stone President, as CEO & President, and Member of the Board of Directors
31 Agosto 2021 - 9:00AM
PetMed Express, Inc. (NASDAQ: PETS), America's Most Trusted Pet
Pharmacy, today announced the appointment of Matt Hulett as its
Chief Executive Officer and President, and member of the Board of
Directors.
Hulett is a seasoned technology executive with
more than 30 years of experience building and leading world-class
digital consumer companies. Hulett has helped lead the growth of
companies in both the private and public sectors, including Rosetta
Stone, Expedia, and RealNetworks, as a public company president as
well as a private company CEO. As President of Rosetta Stone,
Hulett was responsible for driving the transformation and growth
for all aspects of the company's language business, which resulted
in two liquidity events, each of which delivered substantial
shareholder value.
“Matt brings deep experience in using technology
to delight customers as well as a wealth of knowledge gained from
leading numerous digital transformations,” said Dr. Gian Fulgoni,
Board Chairman. “As the market for digital pet pharmacy and
healthcare continues to grow, we look forward to seeing Matt
leverage PetMeds’ many assets and seeing our business flourish
under his leadership.”
Matt Hulett commented, “I am very excited about
the future of PetMeds. Not only is the pet market huge at $100
billion in annual sales with 67 percent of US households owning
pets, but PetMeds has established itself as a trusted leader in
providing critical healthcare to much-loved pets everywhere for
over 25 years. I look forward to leading the company, as it builds
on its solid and profitable foundation and enters new markets to
generate strong growth in the years ahead. Speaking from experience
as a pet parent, pets provide important physical and mental health
benefits to individuals and to society as a whole, and I am deeply
committed to growing businesses that provide meaningful social
impact.”
Founded in 1996, PetMed Express is America’s
Most Trusted Pet Pharmacy ®, providing prescription and
non-prescription pet medications and other health products for
dogs, cats, and horses at competitive prices direct to the consumer
through its website at www.petmeds.com and through its
1-800-PetMeds toll free number. This press release may contain
“forward-looking” statements, as defined in the Private Securities
Litigation Reform Act of 1995 or by the Securities and Exchange
Commission, that involve a number of risks and uncertainties,
including the Company’s ability to meet the objectives included in
its business plan. Important factors that could cause results to
differ materially from those indicated by such “forward-looking”
statements are set forth in Management’s Discussion and Analysis of
Financial Condition and Results of Operations in the PetMed Express
Annual Report on Form 10-K for the year ended March 31, 2021. The
Company’s future results may also be impacted by other risk factors
listed from time to time in its SEC filings, including, but not
limited to, the Company's Form 10-Q and its Annual Report on Form
10-K.
For investment relations contact PetMed Express,
Inc., Bruce S. Rosenbloom, CFO, 561-526-4444.
PetMed Express (NASDAQ:PETS)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
PetMed Express (NASDAQ:PETS)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024